Back to Journal

SM Journal of Gastroenterology & Hepatology

Prediction and Diagnosis of Fatty Liver in Dairy Cows

[ ISSN : 3067-977X ]

Abstract Citation Core Tip Introduction Conclusion References
Details

Received: 20-Mar-2017

Accepted: 17-Apr-2017

Published: 26-Apr-2017

Danijela Kirovski¹* and Zeljko Sladojevic²

¹Department of Physiology and Biochemistry, Faculty of Veterinary Medicine University of Belgrade, Serbia
²Public Veterinary Institute of Republic of Srpska “Vaso Butozan”, Banja Luka, Republic of Srpska, Bosnia and Herzegovina

Corresponding Author:

Danijela Kirovski, Department of Physiology and Biochemistry, Faculty of Veterinary Medicine University of Belgrade, Bulevar oslobodjenja 18, 11 000 Belgrade, Serbia, Tel&Fax: +381 11 2685 936; Email: dani@vet.bg.ac.rs

Keywords

Dairy cows; Fatty liver, Metabolic indicators

Abstract

Fatty liver is defined as an accumulation of fat, mainly Triacylglycerol (TAG) in liver. Fatty liver in dairy cows is categorized into mild, moderate and severe fatty liver. Obesity in pregnant cow is crucial etiological factor for postpartal development of fatty liver. Namely, obese cows have a greater decrease in feed intake during the period around parturition and, therefore, have a more severe negative energy balance during early lactation which leads to increased lipolysis of adipose tissue. Non Esterified Fatty Acids (NEFA), released from the stored TAG in the adipose tissue, are readily taken up by liver. The excess of NEFA may be converted to TAG and deposit in liver. Liver biopsy is the only reliable method for the detection of fatty liver, especially for the determination of its severity through the estimation of total lipids and TAG. Ecography may be considered as noninvasive, on-farm method for diagnosis of fatty liver which is not commonly used do to the not widely achievable equipment. Since some metabolic and endocrine parameters are significantly correlated with fatty liver degree, they may be used as diagnostic indicators of fatty liver. The significance of those indicators for diagnosis of fatty liver is present in this review. Additionally, indicators that may be used for prediction of fatty liver are explained. Specially attention was given to glucose, NEFA, BHBA, liver enzymes, total bilirubin, total protein, albumin and urea as well as some hormones involved in lipid metabolism. Achievements of novel methods, like genomic and proteomic profiling of biological fluids of diseased cows, in providing tools for diagnosis and prognosis of this metabolic disease are presented.

Citation

Kirovski D and Sladojevic Z. Prediction and Diagnosis of Fatty Liver in Dairy Cows. J Gastroenterol. 2017; 3(1): 1005.

Core Tip

Fatty liver is defined as an accumulation of fat, mainly Triacylglycerol (TAG) in liver. Liver biopsy is the only reliable method for the detection of fatty liver, through the estimation of total lipids and TAG. Ecography is non-invasive, on-farm method for diagnosis of fatty liver. Since some metabolic and endocrine parameters are significantly correlated with fatty liver degree, they may be used as diagnostic indicators of fatty liver. Novel methods, like genomic and proteomic profiling of biological fluids of diseased cows, provide reliable tools for diagnosis and prognosis of this metabolic disease.

Introduction

Fatty liver syndrome is one of the most important metabolic diseases in high yielding dairy cows in early lactation. Fatty liver usually develops after calving with peak incidence at about 10 days in milk [1]. It is defined as an accumulation of fat, mainly Triacylglycerol (TAG) in liver. TAG is formed when long-chain fatty acids liver of cows, the fatty acid must come primarily from those mobilized from adipose tissue and taken up subsequently by the liver.

If not cured, fatty liver leads to other metabolic diseases, infective diseases and reproductive disorders. Metabolic diseases that may arise from fatty liver are ketosis, abomasal displacement, puerperal paresis and others. There is growing evidence that the mechanisms of udder defence against mastitis are impaired in periods of negative energy balance and hyperketonemia that are usually coupled with fatty liver. The cow with fatty liver syndrome cannot sustain pregnancy due to disturbed internal signaling system which reduces fertility. Although, it is common that cows with fatty liver do not show clinical signs, the condition is usually associated with health and production problems [2] and consequently with huge economic losses on dairy farms. Despite the economic importance of this disease, it is often misidentified or overlooked due to difficulties in diagnosis [3].

Ethyopathogenesis

Nutritional factors such as obesity are crucial in fatty liver etiology [4]. Obese cows have a greater decrease in feed intake during the peripartal period (3 weeks before to 3 weeks after calving) and, therefore, have a more severe negative energy balance during early lactation [5]. That leads to increased lipolysis of adipose tissue. Nonesterified Fatty Acids (NEFA) that are released from the stored TAG in the adipose tissue are readily taken up by liver where they provide energy for liver function. If more NEFA arrive at the liver that needed for energy purposes, the excess may be oxidized incompletely and generate ketone bodies or be converted to TAG for deposition. Factors that decrease oxidation of fatty acids generally will increase esterification [6]. Carnitin dramatically increase oxidation and decrease estarification in vitro [7], but the adequacy of endogenous carnitin and the effect of exogenous carnitin in vivo are not known. Liver tissue from cows at 14 days postpartum had a greater capacity for esterification of NEFA than liver from the same cows at day 50 after parturition [8]. Estrogen concentrations are one hundred times greater immediately before parturition than during estrus, and may increase TAG synthesis in liver [9]. This effect may be indirect through stimulation of lipolysis, because estrogen had little effect in TAG synthesis by isolated liver cell. Under normal conditions, TAG is secreted from the liver as Very-Low-Density Lipoproteins (VLDL). Inadequate secretion of VLDL may contributes to development of fatty liver. It should be emphases that the rate of TAG production in the liver tissue of ruminants is similar to that found in other species, but the secretion of VLDL from the liver is very limited compared with other species. Additionally, accumulation of hepatic lipids during NEB may further decrease the ability of liver to mobilaze TAG as VLDL [10]. The rate limiting step of VLDL is unknown but is probably limited by the availability of its constituents. Most often cited for limiting VLDL synthesis is the availbility of TAG, Apolipoprotein B-100 (ApoB), and phosphatidyl choline. As disscused by Bauchart et al. [11], the apperent luck of lipases for the hydrolysis of TAG from the cytosol storage pool may limit the incorporation of TAG into VLDL to those which are newly synthesized within the microsomal compartment i.e. secretory pool. However, a mechanism may exist for the transfer of TAG from the cytosolic storage pool that has yet to be identified. As known apolipoprotein B-100 is neccessary for stabilisation of the VLDL particle Interference in the synthesis or proper utilization of the ApoB molecule would than have a deppressing effect on the rate of VLDL synthesis and TAG export from the liver. Gruffat et al. [12] determined that hepatic concentrations of ApoB were lover in early lactating cows compared to pregnant, nonlactating cows. Most animals can synthesyze phosphatidylholine. Nevertheless, animals fed choline and methionine deficient diets offten develop fatty liver [13]. The mechanism of this is associated with VLDL synthesis. Yao and Vance [14] indicated that phosphatydilcholine synthesis is required for the secretion of ApoB in a hepatic cell lines.

Bobe et al [15] indicated that stressors in the animal`s environment, like heat stress, overcrowding, too frequent moves, poorly designed or maintained stalls, lack of water, or suboptimal feeding areas, contribute to development of fatty liver. Namely, those stressors decrease dry matter intake and signal breakdown of body fat around calving.

Inadequate endocrine adjustments during initiation of lactation may play a role in fatty liver pathogenesis. Namely, there is strong relation between endocrine status during the peripartal period, when the homeostatic mechanisms are under the greatest challenges, and postpartal metabolic disorders in dairy cows. It is generally observed that insulin, Insulin like Growth Factor-I (IGF-I) and Thyroid Hormone (TH) concentrations decrease immediately after calving due to the adaptation of organism to negative energy balance and initiation of lactation [16]. Contrarily, secretions of somatotropin and glucagon increase. If reductions are pronounced or not synchronized with other metabolic and endocrine adjustments, the decrease may cause a metabolic disturbance that leads to TAG accumulation in parenchymal tissue, especially the liver. Namely, decreased levels of blood insulin combined with decrease glucose concentrations suppress fat mobilization from adipose tissue and blood NEFA reuptake and reesterification in adipose tissue, leading to increase in blood NEFA concentrations. Decreased levels of TH in blood are associated with reduced mitochondrial capacity to oxidize fatty acids which lead to diffuse lipid infiltration of hepatocytes and pronounce hepatic function impairment. When fatty liver develops, concentrations of those hormones decrease more rapidly. Anyway, the hormonal status of cows in the far-off and mid dry period and its relationship to postpartal metabolic disorders may be of great importance for prediction of fatty liver. Namely, identification of risk factors that are associated with homeorhetic mechanisms leading to metabolic disorders would provide a tool that could be used to better manage cows to prevent fatty liver or provide early warning signs that could be used to segregate cows and mark them for intensive interventional protocols after calving. This strategy requires an understanding of the point in time when adjustments of regulatory mechanisms break through physiological limits thus predisposing the cow to metabolic problems. Our results related to TH concentrations in cows affected with fatty liver showed that cows, that were affected by severe fatty liver during early lactation, were in a hypothyroid state from day 30 before calving (mid dry period) until day 12 after calving (puerperium), which means prior to development of the condition. We concluded that the hypothyroid state during the mid dry period may both be a risk factor and an early indicator of fatty liver, while, during early lactation, it is important etiopathogenetic factor of fatty liver [17]. In the same study, insulin concentrations decreased more pronounced in cows with fatty liver than in healthy cows but only after calving (unpublished data). The same trend was established for IGF-I, since its concentrations decreased more rapidly in cows affected by fatty liver, but only after calving [18].

It should be emphasizes that fatty liver is also associated with altered hormonal sensitivity of adipose tissue and the pancreas. Lipogenesis is less promoted by insulin. Additionally, clearence rates of insulin in hepatocytes and the uptake of glucose by peripheral tissues are decreased [19].

Genetic factors may increase probability of fatty liver due to mutation that affect lipid metabolism in adipose tissue, or lipid metabolism and secretion in the liver. Finally, fatty liver may develop secondary to other diseases and disorders, meaning that factors triggered by trauma or disease may contribute to development of fatty liver. These compounds (cytokines-mainly cachectin and interleukin-1) are released from white blood cells in response to injury and infection, and may increase hepatic conversion of fatty acids to TAG [20].

Categories of fatty liver

Fatty liver may be evaluated either by chemical or histological analysis of liver samples for liver TAG or total lipid [21]. Fatty liver in dairy cows is categorized into mild (liver TAG 1-5% wet weight; total lipid 5-20% of volumen), moderate (liver TAG 5-10% wet weight; total lipid 20-40 % of volumen) and severe fatty liver (liver TAG > 10% wet weight; total lipid > 40% of volume) [22].

Histological pathology of fatty liver

Histological findings in cows with fatty liver include (a) fatty cysts in liver parenchyma; (b) increased volume of individual hepatocytes; (c) mitochondrial damage; (d) compression and decreased volumen of nuclei, rough endoplasmatic reticulum, sinusoids, and other organelles; and (e) decreased number of organelles [23]. Accumulation of TAG in liver with fatty liver is limited to the centrilobular section of the liver near the hepatic vein, but the accumulation extends to the midzonal section and than spreads to the periportal sections in cows with moderate and severe fatty liver. Increased concentrations of liver TAG are accompanied with decreased concentrations of structural lipids (free cholesterol, cholesteryl ester, and phospholipids), energy precursors (citrate), and energy storage molecules (glycogen).

Accumulation of liver TAG in liver reverses slowly and probably has only minor long term negative association with the liver itself because liver cells can regenerate within days. The detrimental associations of fatty liver with other diseases, however, are probably longer and less reversible.

Diagnostic indicators of fatty liver

Liver biopsy is the only reliable method for the detection of fatty liver, especially for the determination of its severity through the estimation of total lipids and triglycerides. Biopsies obtained between 8 and 14 days postpartum are most useful in classifying cows. Liver percutaneous biopsies in dairy cows are obtained using a biopsy instruments as described by Šamanc and coworkers [17]. Namely, the biopsy is usually performed at the right 11th intercostal space, approximately 2 cm below the horizontal line through the tuber coxae. A medium-sized cannula (6 mm o.d. and 4 mm i.d; 20.5 cm long) surrounding a solid, retractable needle-pointed trocar should be inserted through the muscle and peritoneum into the liver in the direction toward the left shoulder. After boring the cannula into the liver, a sample (3 to 5 cm long and 3 to 4 mm in diameter) is obtained through creating a vacuum by drawing back the trocar and then flexing the tip of the cannula upward and gently pushing forward. The liver sample should be expelled onto a clean wipe, blotted free of blood, and placed into storage vials. Liver biopsy provides liver samples for histological measurement of liver fat content. Measurement of glycogen in liver in addition to TAG increases the usefulness of the information, as concentration of TAG and glycogen vary inversely during the early postpartum period [24]. Therefore, it is recommended using rather ratio of liver TAG to liver glycogen, rather than liver TAG alone, as a diagnostic indicator for fatty liver. Nevertheless, liver biopsy is an invasive and time-consuming process, and analytical determination of TAG and glycogen is not well adapted to rapid testing.

Ecography may be considered as non-invasive, on-farm method for diagnosis of fatty liver in dairy cows. As there are correlations between liver TAG and ultrasound images, digital analysis of B-mode ultrasonograms has potential to classify the degree of hepatic fat infiltration and estimate liver TAG content [25]. Due to not widely achievable equipment, echography is not commonly used method for fatty liver diagnosis in dairy cows. The limit of ultrasonography is also linked to the subjective interpretation of the images. Nevertheless, recent studies based on the texture analysis of the ultrasound images show that the measurement of wavelength and the distance of the grayscale pixels may provide a high sensitivity and specificity of the test obtained for measurement of the amount of TAG in the liver [26 28].

Since some metabolic and endocrine parameters are significantly correlated with fatty liver degree, they may be used as diagnostic indicators of fatty liver [29,30]. According to our results, concentrations of puerperal NEFA, BHBA, and total bilirubin are highly positively correlated with fatty liver degree, while glucose, insulin, IGF-I, and thyroid hormone concentrations are highly negatively correlated with fatty liver degree [31]. I our study, we examined those parameters which are suitable for rapid on farm testing. Blood from those kind of testing should be performed from jugular vein [32]. It should be known that the pallet of possible indicator is much wider but the challenge is to choose reasonable number of parameters that will be reliable for diagnosis but low coasted for farmers. Most used parameters for diagnosis are presented in following section with brief explanation of its reliability for fatty liver diagnosis in dairy cows. It should be emphases that each indicator, if analyzed individually, has some deficiency. Therefore overall and combined analysis of all available parameters may lead to more precise diagnosis of fatty liver in dairy cows.

Glucose: Ruminants absorb little glucose from the intestinal tract, but absorb considerable amounts of VFA, mainly acetate, propionate, and butyrate, that are formed in the forestomach through glucose degradation [33]. Thus, circulating glucose in ruminants is derived from gluconeogenesis, primarily in the liver [34], which depends on the availability of glucogenic precursors. Cows that suffer from fatty liver had a decreased hepatic gluconeogenic capacity and consequently lower glucose concentration in blood [35]. The serum level of glucose is good indicators of hepatic functionality and decreases in its concentration may reflect fat infiltration in animals with high lipomobilization. Glucose concentration lower that 2,2 mmol/L indicate on liver imparement in postpartum dairy cows [36].

NEFA and BHBA: The concentration of NEFA is highly related to adipose tissue lipolysis, which increases in response to NEB. Concentrations of NEFA >0.7 mM after the first week postpartum indicate problems with energy balance [37]. Increased amounts of NEFA removed by the liver along with carnitin palmitoyltransferase-1 activity regulate ketogenesis and thus, BHBA production [38]. Therefore, the concentration of BHBA in blood postpartum is an effective indicator of NEB and metabolic disturbance, with concentrations > 1.2 - 1.4 mm indicating presence of subclinical ketosis which is usually associated with fatty liver disease. [39] Use of BHBA is a better indicator of energy imbalance postpartum than NEFA.

Triglycerides: Triglyceride is not adequate indicator of lipolysis in dairy cows. Nevertheless, most of the cows with high lipomobilization had trygliceride values less than 0,1 mmol/L due to accumulation of fat in the liver [40].

Liver enzymes: When fat infiltrates the liver, a lesion appears in the hepatic tissues and the levels of enzymes that indicate liver injury (AST, GGT, and GLDH) are generally augmented. Gonsales et al. [41] found that AST is more sensitive than GGT for detecting hepatic lesions. It was also reported that ornithine carbamoyltransferase (OCT) may be a very sensitive indicator of various degrees of fatty liver. Kalaitzakis et al. [42] showed that OCT increases in parallel with the severity of fatty liver and concluded that its measurement could potentially be used to differentiate animals with mild, moderate, and severe fatty liver. Namely, high serum OCT activity is probably a result of lipid accumulation in hepatocytes that cause dilatation and dysfunction of mitochondria. OCT correlate with AST activity [43].Serum GLDH activity increased with increasing hepatic TG content, allowing the differentiation of moderate and severe fatty liver from mild cases and reference cows, but not the differentiation between moderate and severe fatty liver. Nevertheless, accoridng to meny authors, high variation of enzymes activities in healthy cows make those indicators less realaible in fatty liver diagnosis. liver Besides, enzymes plasma activities correlate with advanced tissue damage which is not usual in mild and moderate fatty liver [44].

Total bilirubin: Total bilirubin concentration may be used as indicator of fatty liver disease. It is significantly elevated in cows with moderate and severe fatty liver groups and can be used to distinguish cows with mild and moderate/severe fatty liver [45]. Nevertheless, hyperbilirubinemia is not necessarily indicative of liver dysfunction, and total bilirubin levels should always be interpreted in association with other tests for liver damage.

Total protein, albumin, urea: The serum levels of total proteins, albumin and urea are indicators of hepatic functionality and decreases in their concentration may reflect fat infiltration in animals with high lipomobilization [46].

Hormones: Changes in concentrations of hormones involved in lipid metabolisam may be used as diagnostic indicators of fatty liver. Pronounced decrease of insulin, IGF-I and thyroid hormone concentrations postpartaly indicate on fatty liver disease [47].

Acute-phase proteins: A number of acute-phase proteins induced (or suppressed) during inflammatory conditions may have merit as diagnostics of metabolic disturbance. According to study done by Imhansly et al. [48], there is the reduction of the fibrinogen serum conten in periparturient cows suffering from fatty liver. As this fibrin precursor is produced in the liver, its lower level may represent a direct consequence of hepatocyte dysfunction due to excessive lipid deposition, but may also result from coagulopathy linked to liver disease [49]. In fact, hyperfibrinolysis leading to hypofibrinogenemia is known to arise from a poor hepatic clearance of tissue plasminogen activator or from reduced hepatic production of fibrinolysis inhibitors.

The indicators for predicting fatty liver

Since overconditioned pregnant cows has lower appetite around parturition and consequentlly more pronanced NEB and lypolisis, obese dry cows has great potential to develop fatty liver postpartaly [50]. Therefore, fatty liver disease, or hepatic lipidosis, is probably the metabolic disorder most associated with excessive Body Condition Score (BCS) during the late dry period. It should be emphasys that in cows, Body Weight (BW) alone is not a good indicator of body reserves, as the relationship is affected by factors such as parity, stage of lactation, frame size, gestation, and breed [51]. In addition, because tissue mobilization in early lactation occurs as feed intake is increasing actual decreases in weight of body tissue can be masked by enhanced gastrointestinal fill, such that BW changes do not accurately reflect changes in adipose and weight of lean tissue. Body condition is defined as the ratio of body fat to nonfat components in the body of a live animal. However, large-scale direct measurements of body adiposity were (and remain) difficult and expensive. As a result, multiple systems to subjectively appraise the stored energy reserves of dairy cattle were introduced in the 1970s and 1980s, and scores were assigned to reflect the degree of apparent adiposity of the cow; these scores were termed “body condition scores.” Lowman and colleagues [52] were the first to introduce a BCS scale (0-5-point system) for dairy cows, adapting a scoring system used to rank beef cattle. BCS higher than 4.0 in late dry cows may be used as indicator for predicting fatty liver in dairy cows.

Fatty liver may be also predicted by identifying those biochemical factors that initiate changes in metabolism that lead to fatty liver. Namely, the etiology of most of the peripartal health disorders including the fatty liver is indirectly or directly provoked by NEB [53]. One research study from Michigen State University found that cows which developed severe fatty liver after calving actually had significant fat accumulation in the liver during the last 3 weeks before calving indicating that lipomobilisation was triggered at that period. According to our results and literature data, elevation of NEFA simultaneously with a decrease of glucose concentrations in the blood 5 to 7 days before calving may be indicators of development of postpartum fatty liver. Most used parameters for prediction of fatty liver are presented in following section with brief explanation of its reliability.

Glucose: Since responses to NEB largely are related to glucose supply and demand, the concentration of glucose in blood may be sensitive indicator of degree of NEB. Namely, a shortage of glucose or gluconeogenic precursors may, among other factors, cause fatty liver [54]. Our results showed that glucose concentration under 2.6 mmol/L 5 to 7 days before calving leads to fatty liver. It should have in mind that concentration of glucose in blood is regulated tightly by the cow and therefore it does not respond to NEB immediately.

NEFA and BHBA: According to many authors, lipolysis which leads to increased concentration of NEFA might be triggered few weeks before calving due to imbalanced nutrition [55,56]. Since high prepartum NEFA is associated with greater risk of postpartum fatty liver increased NEFA concentration can be used as good indicator for fatty liver prediction. Concentrations of NEFA > 0.4 mM prepartum indicate problems with energy balance [57]. Measurement of BHBA before calving is of little use because concentrations rarely begin to increase appreciably until calving. Therefore, use of NEFA is a better indicator of energy imbalance prepartum than BHBA [58].

Hormones: According to our results, hypothyroid condition during the dry period in dairy cows may predispose them to fatty liver and therefore may be used as an indicator for fatty liver prediction.

Refernce values for main blood biochemical parameters in lactating Holstein cows are presented in Table 1 [59-62].

Table 1: Reference values for main blood biochemical parameters in lactating Holstein cows.

 

Parameter

Referene values

Dry period

Early lactation

Glucose (mmol/L)

2.60-4.07

2.31-4.07

BHBA (mmol/L)

˂0.60

˂1.00

NEFA (mmol/L)

˂0.40

˂0.70

Tryglicerides (mmol/L)

0.17-0.50

0.17-0.50

AST (IU/L)

24.84-39.96

45.30-74.28

GGT (IU/L)

4.9-23.65

4.9-25.7

GLDH (IU/L)

˂30.0

˂30.0

Total bilirubin (ɲmol/L)

˂8.55

˂8.55

Total protein (g/L)

69.00-85.00

73.00-89.00

Albumin (g/L)

34.06-42.00

35.00-45.00

Urea (g/L)

1.90-7.80

2.78-8.78

Novel indicators of fatty liver obtained by genomic and proteomic analyses

As mantioned above, the diagnosis of fatty liver can only be confirmed by taking biopsies to determine the hepatic lipid content. Biochemical abnormalities are not usually specific for hepatic lipidosis. Thus, in view of the lack of a practically useful diagnostic tool, an alternative strategy was explored by screening for small-molecule serum biomarkers that . As indicated above, an important new paradigm in biomarker discovery research is to consider entire sets of molecular changes, instead of single parameters, that correlate with a particular disease. Imhasly et al [63] used a targeted metabolomics screen by triple quadrupole mass spectrometry to identify those serum biomarkers that distinguish cows with hepatic lipidosis from those affected by other peripartal disorders. This method yielded 29 metabolites. The authors concluded that metabolomic profiles, including both amino acids and lipids, distinguish hepatic lipidosis from other peripartal disorders and, hence, provide a promising new tool for the diagnosis of hepatic lipidosis.

One of the significant areas of research is the study of gene expression in liver using “microarray“techniques. These procedures allow quantification of the mRNA expression of thousands of gene sequences simultaneously on a microscope slide-sized glass plate. There are studies that confirmed that liver cellular function was impaired in cows that suffered from fatty liver disease [64]. Those impairments include: (1) down down-regulation of genes responsive to oxidative stress, but increase of potential sources of oxidants; (2) up-regulation of genes indicating enhanced DNA fragmentation and apoptosis; (3) blunted repair response to DNA damage; (4) down regulation of components of oxidative phosphorylation, suggesting that the liver’s ability to generate ATP for its functions eventually may be impaired; (5) down-regulation of enzymes in cholesterol synthesis, which may impair VLDL export and contribute to greater TG accumulation; (6) downregulation of growth hormone signaling mechanism, which may disrupt normal homeostatic and homeorhetic controls; (7) down-regulation of ubiquinone synthesis and ubiquitination activity, which are involved in targeting damaged or aberrant proteins for degradation; and (8) down-regulation of components of the immune system.

Clinical disease is triggered when accumulative cell damage in liver prevents maintenance of homeostasis. Key functions that are compromised includes mitochondrial energy status, accumulation of aberrant proteins that cannot be properly cleared, and induction of apoptosis (programmed cell death). Consequently, it may be concluded that those cell impairment may be used not only for diagnosis but also for prognosis of fatty liver disease in dairy cows.

Conclusion

In conclusion, despite the numerous published papers that analyzes possible biomarkers of fatty liver in dairy cows there is no individual metabolite that may be considered as reliable to predict fatty liver in dairy cows. Therefore, further research on molecular level are required for establishing relationships between molecular changes in damaged hepatic cells and blood biochemical changes in cows suffered from fatty liver disease.

References

1. Mulligan FJ, Doherty ML. Production diseases of the transition cow. Vet J. 2008; 176: 3-9.

2. Geelen MJ, Wensing T. Studies on hepatic lipidosis and coinciding health and fertility problems of high-producing dairy cows using the “Utrecht fatty liver of dairy cows”. A review. Vet Q. 2006; 28: 90-104.

3. Kalaitzakis E, Panousis N, Roubies N, Giadinis N, Kaldrymidou E, Georgiadis M, et al. Clinopathological evaluation of downer dairy cows with fatty liver. Can Vet J. 2010; 51: 615-622.

4. Rukkwamamsuk T, Kruip TA, Wensing T. Relationship between overfeeding and over conditioning in the dry period and the problems of high producing dairy cows during the post parturient period. Vet Q. 1999; 21: 71-77.

5. Allen MS, Piantroni P. Metabolic control of feed intake: implications for metabolic disease of fresh cows. Vet Clin North Am Food Anim Pract. 2013; 29: 279-297.

6. Armetano LE, Grummer RR, Bertics SJ, Skaar TC, Donkin SS. Effects of energy balance on hepatic capacity for oleate and propionate metabolism and trygliceride secretion. J Dairy Sci. 1991; 74: 132-139.

7. Drackly JK, Beitz DC, Young JW. Regulation of in vitro palmitate oxidation in liver from dairy cows during early lactation. J Dairy Sci. 1991; 74: 1884-1892.

8. Veenhuizen JJ, Drackly JK, Richard MJ, Sanderson TP, Miller LD, Young JW. Metabolic changes in blood and liver during development and early treatment of experimental fatty liver and ketosis in cows. J Dairy Sci. 1991; 74: 4238-4253.

9. Grummer RR, Bertics SJ, Lacount DW, Snow JA, Dentine MR, Stauffacher RH. Estrogen induction of fatty liver in dairy cattle. J Dairy Sci. 1990; 73: 1537-1543.

10. Van den Top AM, Van Tol A, Jansen H, Geelen MJ, Beynen AC. Fatty liver in dairy cows post partum is associated with decreased concentration of plasma triacyglycerols and decreased activity of lipoprotein lipase in adipocytes. J Dairy Res. 2005; 72: 129-137.

11. Bauchart D, Gruffat D, Durand D. Lipid absorption and hepatic metabolism in ruminants. Proc Nutr Soc. 1996; 55: 39-47.

12. Gruffat D, Durand D, Chiliard Y, Wiliams P, Bauchart D. Hepatic gene expression of apolipoprotein B100 during early lactation in underfed, high producing dairy cows. J Dairy Sci. 1997; 80: 657-666.

13. Bertics SJ, Grummer RR. Effect of fat and methionine hydroxyl analog on prevention or alleviation of fatty liver induced by feed restriction. J Dairy Sci. 1999; 82: 2731-2736.

14. Yao ZM, Vance DE. The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. J Biol Chem. 1988; 263: 2998-3004.

15. Bobe G, Young JW, Beitz DC. Invited review: pathology, etiology, prevention, and treatment of fatty liver in dairy cows. J Dairy Sci. 2004; 87: 3105-3124.

16. Stojic V, Gvozdic D, Kirovski D, Nikolic JA, Huszenicza G, Samanc H, et al. Serum thyroxine and triiodothyronine concentrations prior to and after delivery in primiparous Holstein cows. Acta Veterinaria-Beograd. 2001; 51: 3-8.

17. Samanc H, Stojic V, Kirovski D, Jovanovic M, Cernescu H, Vujanac I. Thyroid hormones concentrations during the mid-dry period: an early indicator of fatty liver in Holstein - Friesian dairy cows. Journal of Thyroid Research. 2010: 897602.

18. Kirovski D, Samanc H, Vujanac I, Stojic V, Sladojevic Z, Lazarevic M, et al. Effect of peripartum dietary energy supplementation on insulin-like growth factor-I, its binding proteins and thyroid hormones in early lactation dairy cows. Acta Veterinaria-Beograd. 2010; 62: 403-419.
 

19. Ohtsuka H, Koiwa M, Hatsugaya A, Kudo K, Hoshi F, Itoh N, et al. R relationship between serum TNF activity and insulin resistance in dairy cows affected with naturally occuring fatty liver. J Vet Med Sci. 2001; 63: 1021-1025.

20. Reddy JK, Rao MS. Lipdi metabolism and liver inflammation II. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastrointest Liver Physiol. 2006; 290: 852-858.

21. Collins RA, Reid IM, Williams LA, Dennis PF. Histological measurement of fat content of liver of dairy cows. J Comp Pathol. 1985; 95: 437-441.

22. Gaal T, Reid IM, Collins RA, Robert CJ, Pike BV. Comparison of biochemical and histological methods of estimating fat content of liver of dairy cows. Res Vet Sci. 1983; 34: 245-248.

23. Johannsen U, Menger S, Staufenbiel R, Klukas H. The morphology and function of the liver in high performance cows 2 weeks post partum. Deut Tierarztl Woch. 1993; 100: 177-181.

24. Kuhla B, Albrecht D, Kuhla S, Metges CC. Proteome analysis in feed-deprived dairy cows revels interaction of fuel sensing, calcium, fatty acid, and glycogen metabolism. Physiol Genomics. 2009; 37: 88-98.

25. Bobe G, Amin VR, Hippen AR, She P, Young JW, Beitz DC. Non-invasive detection of fatty liver in dairy cows by digital analyses of hepatic ultra sonograms. J Dairy Res. 2008; 75: 84-89.

26. Banzato T, Fiore E, Morgante M, Manueli E, Zotti A. Texture analysis of B-mode ultrasound images to stage hepatic lipidosis in the dairy cow: A methodological study. Res Vet Sci. 2016; 108: 71-75.

27. Lee CH, Choi JW, Kim KA, Seo TS, Lee JM, Park CM. Usefulness of standard deviation on the histogram of ultrasound as a quantitative value for hepatic parenchymal echo texture; preliminary study. Ultr Med Biol. 2006; 32: 1817-1826.

28. Acorda JA, Yamada H, Ghamsari SM. Evaluation of fatty infiltration of the liver in dairy cattle through digital analysis of hepatic ultra sonograms. Vet Radiol Ult. 1994; 35: 120-123.

29. Fiore E, Piccione G, Perillo L, Barberio A, Manuali E, Morgante M, et al. Hepatic lipidosis in high-yielding dairy cows during the transition period: haematochemical and histopathological findings. Anim Prod Sci. 2015; 57: 74-80.

30. Fiore E, Barberio A, Morgante M, Rizzo M, Giudice E, Piccione G, et al. Glucose infusion response to some biochemical parameters in dairy cows during the transition period. Anim Sci Papers and Reports. 2015; 33: 129-136.

31. Samanc H, Kirovski D, Stojic V, Stojnovic D, Vujanac I, Prodanovic R, et al. Application of the metabolic profile test in the prediction and diagnosis of fatty liver in Holstein cows. Acta Veterinaria-Beograd. 2011; 61: 543-553.

32. Samanc H, Kirovski D, Lakic N, Celeska I, Bojkovic-Kovacevic S, Sladojevic Z, et al. A comparison of the concentrations of energy-balance-related variables in jugular and mammary vein blood of dairy cows with different milk yield. Acta Veterinaria Hungarica. 2014; 62: 52-63.

33. Herdt TH. Metabolic diseases of ruminant livestock: fuel homeostasis in the ruminant. Vet Clin North Am Food Anim Pract. 1988; 4: 213-231.

34. Young JW. Gluconeogenesis in cattle: significance and methodology. J Dairy Sci. 1977; 60: 1-15.

35. Rukkwamsuk T, Wensing T, Geelen MJ. Effect of fatty liver on hepatic gluconeogenesis in periparturient dairy cows. J Dairy Sci. 2010; 82: 500-505.

36. Mohamed T, Oikawa S, Iwasaki Y, takehana K, endoh D, Kurosawa T, et al. Metabolic profiles and bile acid extraction rate in the liver of cows with fasting-induced hepatic lipidosis. J Vet Med A Physiol Pathol Clin Med. 2004; 51: 113-118.

37. Oetzel GR. Monitoring and testing dairy herds for metabolic disease. Vet Clin north Am Food Anim Pract. 2004; 20: 651-674.

38. Hegardt FG. Mitocholndial 3-hydroxy-3-methylglutaryl-CoA synthase: a control enzyme in ketogenesis. Biochem J. 1999; 338: 569-582.

39. Duffield TF, Lissemore KD, McBride BW, Leslie KE. Impact of hyperketonemia in early lactation dairy cows on health and production. J Dairy Sci. 2009; 92: 571-580.

40. Gross JJ, Shwarz FJ, Eder K, van Dorland HA, Bruckmaier RM. Lipid fat content and lipid metabolism in dairy cows during early lactation and during a mid-lactation feed restriction. J Dairy Sci. 2013; 96: 5008-5017.

41. Gonzalez FD, Muino R, Pereira V, Campos R, Benedito JL. Relationship among blood indicators of lipomobilization and hepatic function during early lactation in high-yielding dairy cows. J Vet Sci. 2011; 12: 251-255.

42. Kalaitzakis E, Roubies N, Panousis N, Pourliotis K, Kaldrymidou E, Karatzias H. Clinicopathologic evaluation of hepatic lipidosis in periparturient dairy cattle. J Vet Intern Med. 2007; 21: 835-845.

43. Johannsen DL, Ravussin E. The role of mitochondria in health and disease. Curr Opin Pharmacol. 2009; 9: 780-786.

44. Bergmeyer HU, Horder M, Rej R. International federation of clinical chemistry (IFCC) scientific committee, analytical section: approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 2. IFCC method for aspartate aminotransferase (L-aspartate: 2-oxoglutarate aminotransferase, EC 2.6.1.1). J Clin Chem Clin Biochem. 1986; 24: 497-510.

45. Acorda JA, Yamada H, Ghamsari SM. Comparative evaluation of fatty liver in dairy cattle by using blood and serum analysis, ultrasonography, and digital analysis. Vet Q. 1995; 17: 12-14.

46. West HJ. Liver function of dairy cows in late pregnancy and early lactation. Res Vet Sci. 1989; 46: 231-237.

47. Hammon HM, Stürmer G, Schneider F, Tuchscherer A, Blum H, Engelhard T, et al. Performance and metabolic and endocrine changes with emphasis on glucose metabolism in high-yielding dairy cows with high and low fat content after calving. J Dairy Sci. 2009; 92: 1554-1566.

48. Graungard DE, Moyes KM, Trevisi E, Khan MJ, Keisler D, Drackley JK, et al. Liver lipid content and inflammometabolic indices in peripartal dairy cows are altered in response to prepatal energy intake and postpartal intramammary inflammatory challenge. J Dairy Sci. 2013; 96: 918-935.

49. Pluta A, Gutkowski K, Hartleb M. Coagulopathy in liver diseases. Adv Med Sci. 2010; 55: 16-21.

50. Rukkwamsuk T, Kruip TA, Wensing T. Relationship between overfeeding and over conditioning in the dry period and the problems of high producing dairy cows during the post parturient period. Vet Q. 1999; 21: 71-77.

51. Roche JR, Dillon PG, Stockdale CR, Baumgard LH, VanBaale MJ. Relationship among international body conditing scoring. J Dairy Sci. 2004; 87: 3076-3079.

52. Lowman BG, Scott NA, Scott PR. An evaluation of some breeding management options in beef herds in the United Kingdom. Vet Rec. 1994; 135: 9-12.

53. van Knegsel AT, van der Drift SG, Cermáková J, Kemp B. Effect of shortening the dry period of dairy cows on milk production, energy balance, health and fertility: a systematic review. Vet J. 2013; 198: 707-713.

54. Nafikov RA, Beitz DC. Carbohydrate and lipid metabolism in farm animals. J Nutr. 2007; 137: 702-705.

55. Schwegler E, Schneider A, Montagner P, Acosta DA, Pfeifer LF, Schmitt E, et al. Predictive value of prepartum serum metabolite for incidence of clinical and subclinical mastitis in grazing primiparous Holstein cows. Trop Anim Health Prod 2013; 45: 1549-1555.

56. Guedon L, Saumande J, Desbals B. Relationship between calf birth weight, prepartum concentration of plasma energy metabolites and resumption of ovulation postpartum in Limousine suckled beef cows. Theriogenology. 1999; 52: 779-789.

57. McArt JA, Nydam DV, Oetzel GR, Overton TR, Ospina PA. Elevated non-esterifield fatty acids and β-hydroxytyrate and their association with transition dairy cow performance. Vet J. 2013; 198: 560-570.

58. Ospina PA, Nydam DV, Stokol T, Overton TR. Association between the proportion of sampled transition cow with increased nonesterified fatty acid and beta-hydroxybutyrate and disease incidence, pregnancy rate, and milk production at the herd level. J Dairy Sci. 2010; 93: 3595-3601.

59. Kaneko JJ, Harvey JW, Bruss ML. Clinical Biochemistry of Domestic Animals (Sixth edition). Elsevier 2008; 928.

60. Quiroz-Rocha GF, LeBlanck SJ, Duffield TF, Wood D, Leslie KE, Jacobs RM. Reference limits for biochemical and haematological analytes of dairy cows one week before and one week after parturition. Can Vet J. 2009; 50: 383-388.

61. Cozzi G, Ravarotto L, Gottardo F, Stefani AL, Contiero B, Moro L, et al. Reference values for blood parameters in Holstein dairy cows: Effects of parity, stage of lactation, and season of production. J Dairy Sci. 2011; 94: 3895-3901.

62. Samanc H, Kirovski D, Stojic V, Stojanovic D, Vujanac I, Prodanović R, et al. Application of the metabolic profile test in the prediction and diagnosis of fatty liver in Holstein cows. Acta Vet Beograd 2011; 61: 543-553.

63. Imhasly S, Naegeli H, Baumann S, von Bergen M, Luch A, Jungnickel H, et al. Metabolomic biomarkers correlating with hepatic lipidosis in dairy cows. BMC Vet Res. 2014; 10.

64. Molette C, Theron L, Marty-Gasset N, Fernandez X, Remignon H. Current advances in proteomic analysis of (fatty) liver. J Proteomics. 2012; 75: 4290-4295.

Other Articles

Article Image 1

Outcomes and Safety of Open vs. Laparoscopic Surgery in Patients with Cirrhosis

Background & Aims: The risk of laparoscopic surgery in cirrhotics remains unclear. We report on outcome and safety of open versus laparoscopic surgery in cirrhotics.

Methods: Retrospective review of cirrhotics undergoing abdominal or pelvic surgery at a university hospital from 2000 to 2010. Pre-, intra-, and post-operative data was collected. Open and laparoscopic patients were compared for post-operative outcomes including minor and major complications, hepatic decompensation, and mortality. Patients were stratified by Child-Pugh and MELD scores, and emergent vs. elective surgery. 164 total patients were identified (131 open and 31 laparoscopic).

Results: There was significantly more intra-operative blood loss (p<0.001) and minor complications (p=0.043) in the open group, but no other significant differences between the laparoscopic and open patients. All 5 deaths occurred in open patients (p=0.58). Increasing Child and MELD scores were predictive of adverse events. Overall complications, hepatic decompensation (p=0.015) and death (p<0.022) were more common in open emergent compared to open elective cases. In open emergent Child C patients, 100% had major complications and hepatic decompensation and 67% died. Of emergent open MELD>20 patients, 100% had major complications, 67% had hepatic decompensation, and 33% died.

Conclusion: Open and laparoscopic surgical approaches for cirrhotics yielded similar safety and outcomes. Child and MELD scores were predictive of adverse outcomes. Emergent cases were more likely to have complications than elective cases. Further studies including larger numbers of emergent laparoscopic patients are needed to better ascertain the risk of laparoscopy in cirrhotics.

Stanley Martin Cohen¹*, Aditya Dholakia², Thomas R VanderHeyden³, Anjana Pillai⁴ and Joseph Ahn⁵


Article Image 1

Case Series and a Review of Cannabinoid Hyperemesis Syndrome

Cannabinoid hyperemesis syndrome (CHS) is a condition observed in patients with chronic use of cannabis. It is characterized with GI symptoms including nausea, vomiting, abdominal pain and diarrhea. The patients tend to be chronic abusers for several years and experience these symptoms in a cyclical manner similar to the cyclical vomiting syndrome. They find relief after taking hot baths, a pathognomonic feature of CHS. We hereby describe 3 cases who presented with clinical features consistent with CHS. Cannabis acts through CB1 and CB2 receptors located in brain and gastrointestinal tract, respectively. There are no standard therapeutic measures available for management of CHS. We propose the idea of using short-acting cannabinoids including dronabinol. Also review of literature suggests treatments with drugs including clonidine, lorazepam and risperidone. Recent endeavors on legalization of recreational cannabis use have initiated several debates and we should be mindful of CHS as one of its long-term complications.

Yezaz A Ghouri¹, Jay Chouhan¹, Lauren Hoffman³ and Sushovan Guha¹,²*


Article Image 1

Pharmacological Characterization of Muscarinic Receptor Subtypes Involved in Carbachol-Induced Contraction of the Chicken Proventriculus

Present study was designed to characterize the postjunctional muscarinic acetylcholine receptor mediating contraction of the chicken proventriculus by using muscarinic receptor agonists and antagonists. Muscarinic agonists caused concentration-dependent contraction. The ranking order of pEC50 values were muscarine > arecaidine propargyl ester > oxotremorine M > carbachol > methacholine > arecoline > acetylcholine > bethanechol = McN-A343 = pilocarpine. The responses to carbachol were competitively antagonized by AF-DX116 (pKb =5.9), AF-DX384 (6.84), 4-DAMP (8.79), methoctramine (5.81), pirenzepine (6.78), p-F-HHSID (7.41), atropine (8.43),tropicamide (6.91), himbacine (7.01), AQ-RA741 (6.6) and dimethindene (6.73). The correlation of pKb of the chicken proventriculus with that of the mammalian M3 receptor was the highest among five muscarinic receptors. The proventriculus membrane contained a single class of [3 H]-quinuclidinyl benzilate binding sites. pKi values of the antagonists in a binding displacement study correlated with that of the M3 subtype. Pertussis toxin(100µg/kg, i.p. for 72h) significantly decreased the contraction induced by a low concentration of carbachol. In 4-DAMP mustard and AF-DX116-pretreated muscle strips, AF-DX116 shifted the concentration-response curve for oxotremorine M to the right in the presence of 5-hydroxytryptamine and forskolin. The pKb value (6.22) was significantly higher than that obtained in the normal condition (5.78). Isoproterenol increased cyclic AMP, and carbachol significantly decreased the isoproterenol-induced increase in cyclic AMP. The results indicated that a muscarinic agonist mainly acts on the M3 receptor to cause contraction of the chicken proventriculus but the possible involvement of M2 /M4 receptors cannot be excluded as demonstrated in mammalian gastrointestinal tract.

Takio Kitazawa¹*, Nahoko Kondo¹ and Tetsuro Taneike¹


Article Image 1

A Case Report on Ulcerative Colitis with Interventional Outcomes

Ulcerative Colitis (UC) is a mucosal disease that usually involves the rectum and extends proximally to involve all or part of the colon. Main causes are gut microbiota, dysregulation of the host’s immune system, genetic susceptibility and environmental factors. Active disease can be associated with a rise in acute phase reactants [C - reactive protein (CRP)], platelet count and Erythrocyte Sedimentation Rate (ESR) and a decrease in hemoglobin. Colonoscopy is used to assess disease activity and is often performed before treatment. In this case, recurrence UC was observed and it was treated with suitable therapy but some drug interactions like metronidizole additive effect with ofloxacin results in ST-T elevation and adverse effects like abdominal pain, burning pain in midsternal area radiating to epigastric region [Calcium+Vitamin-D] were seen. Those are monitored by the alternative therapy like dose management and drug alterations.

Sandeep RJ¹, Hari HC², Jyothsna RD² and Mahender V²*


Article Image 1

Primary Gastric Lymphoma

The treatment of primary gastric lymphoma is evolving in post-rituximab era. The role of Helicobacter pyroli eradication alone can cure not only Mucosa-Associated Lymphoepithelial Tumor (MALT) but also some of diffuse large B cell lymphoma with or without MALT component. The efficacy of rituximab containing chemotherapy is so effective that the role of surgery is overshadowed. There are many studies, although most of them were retrospective trials, however it highlights the current mainstay of immune-chemotherapy provided an outstanding long term survival more than 80-90%.H pylori In real world there are substantial patients may receive surgery first, yet still needs post-operative adjuvant chemotherapy for some of them has a risk of relapse of lymphoma. And recent studies showed there’s no statistical difference between the two modalities. The main reason for patients proceeded to surgery as primary treatment is the gastroenterologist preference and showed no difference in terms of progression free survival and overall survival. The rituximab was introduced to lymphoma treatment since 1999, and demonstrated a superior long term survival in diffuse large B cell lymphoma for R-CHOP relatively to CHOP regimen. The highly effective treatment made PGL being easily curable disease; furthermore there are new insights of why and how the antibiotic therapy as exclusive treatment for limited disease will be a mainstay in treating this malignancy. We make a proposal how to treat the primary gastric lymphoma and MALT, and highlight the changing treatment modalities with regards to the integration of Helicobacter pyroli eradication to conventional chemotherapy as well as the complimentary role of surgery and radiotherapy.

Ming-Chih Chang¹* and Sung-Hsin Kuo²*


Article Image 1

Bleeding Peptic Ulcer: Epidemiology, Treatment and Prognosis

Aims: The aim of this study was to demonstrate epidemiological, clinical and endoscopic characteristics of acute Upper Gi Bleeding (UGIB) with a focus on Peptic Ulcer Bleeding (PUB).

Methods: This study included 2198 consecutive patients that were referred to our emergency department due to acute Upper Gi Bleeding (UGIB) from January 2008 to December 2012. All patients under went urgent upper GI endoscopies within 24 hours of admission, and 842 patients diagnosed with PUB were enrolled and prospectively followed.

Results: The cumulative incidence of UIGB was 126/100000 for a 5-year period. Two out of five patients had a bleeding peptic ulcer, of which 440 (52.3%) patients had a bleeding gastric ulcer, 356 (42.3%) had a bleeding duodenal ulcer, 17 (2%) had both bleeding gastric and duodenal ulcers and 29 (3.5%) patients had bleeding ulcers on gastroenteric anastomosis. PUB was more common in men. Average patient age was 65.9 years. The majority of patients with PUB were taking agents that attenuate the cytoprotective function of the gastric and duodenal mucosa (57%).Half of the patients received a red blood cell transfusion, with a median of 2.2 units. Re-bleeding occurred in 77(9.7%) patients and 47 (5.9%) required surgical intervention. The thirty-day morality was 5.2%, and 10% of patients died from uncontrolled bleeding and concomitant diseases.

Conclusion: PUB is the main cause of UGIB, characterized by a significant re-bleeding rate and mortality.

Budimir I¹, Stojsavljevic S¹*, Nikolic M¹, Kralj D¹, Biscanin A¹, Kirigin LS², Zovak M³, Babic Z⁴, Bohnec S⁵ and Budimir I⁶


Article Image 1

An Update on Hepatorenal Syndrome

The Hepatorenal Syndrome (HRS) is one of many potential causes of Acute Kidney Injury (AKI) in patients with decompensated liver disease.

HRS is associated with poor prognosis and represents the end-stage of a sequence of reductions in renal perfusion induced by progressively severe hepatic injury.

The pathophysiology of HRS is complex with multiple mechanisms interacting simultaneously, although HRS is primarily characterised by renal vasoconstriction.

A recently revised diagnostic criteria and management algorithm for AKI has been developed for patients with cirrhosis, allowing physicians to commence treatment promptly.

Vasopressor therapy and other general management, such as antibiotic prophylaxis, need to be initiated while patients are assessed for eligibility for transplantation. Liver transplantation remains the treatment of choice for HRS but is limited by organ shortage.

Other management options, such as transjugular intrahepatic portosystemic shunt, renal replacement therapy and molecular absorbent recirculating system, may provide short term benefit for patients not responding medical therapy while awaiting transplantation.

Clinicians need to be aware of the pathophysiology and management principles of HRS to provide quality care for patients with multi-organ failure.

Samuel Chan*


Article Image 1

Abdominal CT Findings of Cholecystogastric Fistula

Enteric fistulas are abnormal connections between the gastrointestinal tract and other organs, chest or skin. Fistulas between the gall bladder and the gastrointestinal system are common [1]. Cholecystoduodenal and cholecystocolic fistulas are seen frequently while cholecystogstric ones are rare [2]. In our case, we accidentally discovered a cholecystogastric fistula in a 71 years old male patient with gastric adenocarcinoma in orally and intravenous contrast enhanced abdomen CT.

Husam Vehbi¹* and Cagri Agirgun²


Article Image 1

Post-Colonoscopy Colorectal Carcinomas (PostCRCs): Have we Improved Over Time?

Background and Aim: There is an increasing concern on Post-Colonoscopy Colorectal Carcinomas (PostCRCs). Little is known about how these figures have evolved over time. We aim to compare the rates of PostCRCs in two periods of time and identify the risk factors.

Methods: Retrospective control-case study in our Endoscopic Unit. We studied two separate intervals (March 2004-September 2011 and October 2011 - December 2016). In both periods of time all patients diagnosed with CRC were identified. Patients with a previous colonoscopy performed 12 to 60 months before were retrieved (cases) and compared with those who did not have a previous procedure (controls).

Results: 712 and 743 patients diagnosed with CRC in both periods of time. 24 patients in the first period (3.6%) and 28 patients in the second one (3.8%) had a previous colonoscopy performed. PostCRCs were mainly located on the right side of the colon (63% vs. 35% p=0.006 and 68% vs. 33% p< 0.001), were smaller in size (3.17 vs.4.46 p< 0.001 and 3.61 vs. 4.44 p=0.086), with a tendency to host a better TNM stage. No differences in sex and age were found.

More than half of PostCRCs (58.3% and 60.7%) were attributed to procedure causes, meanwhile10 PostCRCs in both periods were considered new developed CRCs.

Conclusions: Despite what could be expected, we did not find a decrease in the rate of PostCRCs over time. A combination of preventable as much as biological factors would account for their etiology.

María Lourdes Ruiz Rebollo¹* and María Fe Muñoz Moreno²


Article Image 1

Renal Metastasis from Mucinous Adenocarcinoma of the Colon in a 70 Year Old Male: A Case Report

Distal Metastasis of Colorectal Cancer (CRC) mostly spread to the lymph node, liver, peritoneum and lung. The kidney metastasis from colorectal cancer considered to be unusual and rare sites of metastasis. The most important factor which affects the prognosis of colorectal cancer is distal metastasis. The present study reported the case of a 70-yr-old Saudi man metastatic mucinous adenocarcinoma of the colon in the right kidney at the time of initial presentation.

Sultan H AlSaigh¹* and Aseel A AlSaeed²